At present, several questions regarding TOP2A in cancer cells remain unanswered, such as, how are TOP2A amplified genes regulated, whether genes are amplified in one piece or in fragments, or whether they lack regulatory regions, what are the genomic profiles of relapsed/metastatic vs. primary tumors, especially if treatment has been administered, and so on. This evidence concerns the gene TOP2A and cancer.